COVID-19 vaccination preferences during a pause in Johnson & Johnson vaccine administration

COVID-19 vaccination preferences during a pause in Johnson & Johnson vaccine administration

Blog Article

In April 2021, the US paused Janssen (J&J) COVID-19 vaccination because of reported blood clots post vaccination.This paper explores how vaccine decision-making--receiving a J&J vaccine right away vs waiting for a copyright the flash batman poster vaccine--changed during the pause.In an opt-in internet-based survey April 2021 with 915 participants, 37 % were not vaccinated.Of these, 18 % would accept a J&J vaccine, 5 % would wait 1 month for a copyright vaccine, 25 % would wait 3 months, and 52 chorulon hcg % would not want any vaccine.

Among the unvaccinated, 56 % had heard of blood clots; 61 % of these did not want any vaccine, compared to 41 % of those who had not heard of blood clots.Moreover, among those vaccine hesitant in general, 11 % would still obtain a J&J vaccine if offered right away.These findings may suggest spillover of brand-specific adverse event concerns to the vaccine product as a whole.